1. hMSH2 expression is associated with paclitaxel resistance in ovarian carcinoma, and inhibition of hMSH2 expression in vitro restores paclitaxel sensitivity
   JIN ZHANG et al, 2014, Oncology Reports CrossRef
2. Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas
   Alice Bergamini et al, 2015, Expert Opinion on Investigational Drugs CrossRef
3. Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
   Jin Zhang et al, 2019, Oncology Letters CrossRef
4. S-Phase Cell Cycle Arrest, Apoptosis, and Molecular Mechanisms of Aplasia Ras homolog Member I–Induced Human Ovarian Cancer SKOV3 Cell Lines
   Qiaoying Zhu et al, 2014, International Journal of Gynecologic Cancer CrossRef
5. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI
   XIAOXIAO ZUO et al, 2014, Oncology Reports CrossRef